Breaking News

You are here » Indian-Commodity  :  Commodities  :  Turmeric  :  Turmeric futures exhibit mixed trend on NCDEX


Turmeric futures exhibit mixed trend on NCDEX

Turmeric futures showed mixed trend on NCDEX as November contract edged lower as good supplies from the government auctions and arrivals of medium quality supplies pressurized prices. While, December contract edged up amid strong demand in the spot market.

The contract for November delivery was trading Rs 7100.00, down by 0.14% or Rs 10.00 from its previous closing of Rs 7110.00. The open interest of the contract stood at 40 lots.

The contract for December delivery was trading at Rs 7116 .00, up by 1.19% or Rs 84.00 from its previous closing of Rs 7032.00. The open interest of the contract stood at 6740 lots on NCDEX.

Related News

View all news

Turmeric futures trade lower on rise in arrivals

Turmeric futures traded lower on NCDEX, due to increased selling by speculators taking off the prevailing profits followed by decline in exports and domestic demand, amid increased acreage of......

Turmeric futures trade higher on firm demand

Turmeric futures traded higher on NCDEX, with the widening of portfolios by market participants tracking firm domestic and export demands. Even though, improved acreage and higher arrivals from growing......

Turmeric futures edge lower on higher acreage

Turmeric futures edged lower on NCDEX, as speculators reduced exposure on account of decline in export demand. Moreover, expectations of better crop this season, amid reports of increase in acreage compared......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......